1-4 of 4
R Stone
Close
Sort by
Journal Articles

Expansion of HIV-specific CD4 + and CD8 + T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted Nef

Daniel G. Kavanagh, Daniel E. Kaufmann, Sherzana Sunderji, Nicole Frahm, Sylvie Le Gall, David Boczkowski, Eric S. Rosenberg, David R. Stone, Mary N. Johnston, Bradford S. Wagner, Mohammad T. Zaman, Christian Brander, Eli Gilboa, Bruce D. Walker, Nina Bhardwaj
Journal: Blood
Blood (2006) 107 (5): 1963–1969.
https://doi.org/10.1182/blood-2005-04-1513
Published: 2006
Journal Articles

Phase 1 Study of PKC412, an Oral FLT3 Kinase Inhibitor, in Sequential and Concomitant Combinations with Daunorubicin and Cytarabine (DA) Induction and High-Dose Cytarabine (HDAra-C) Consolidation in Newly Diagnosed Patients with AML.

Francis Giles, C. Schiffer, H. Kantarjian, T. Fischer, R. Paquette, D. M. Pelov, D. J. Resta, P. S. Cohen, Y. F. Wang, R. Stone
Journal: Blood
Blood (2004) 104 (11): 262.
https://doi.org/10.1182/blood.V104.11.262.262
Published: 2004
Journal Articles

Fatal hepatic necrosis following imatinib mesylate therapy

Nancy U. Lin, Stefanie Sarantopoulos, James R. Stone, Ilene Galinsky, Richard M. Stone, Daniel J. Deangelo, Robert J. Soiffer
Journal: Blood
Blood (2003) 102 (9): 3455–3456.
https://doi.org/10.1182/blood-2003-07-2323
Published: 2003
Journal Articles

Hexamethylene bisacetamide in myelodysplastic syndrome and acute myelogenous leukemia: a phase II clinical trial with a differentiation- inducing agent

M Andreeff, R Stone, J Michaeli, CW Young, WP Tong, H Sogoloff, T Ervin, D Kufe, RA Rifkind, PA Marks
Journal: Blood
Blood (1992) 80 (10): 2604–2609.
https://doi.org/10.1182/blood.V80.10.2604.2604
Published: 1992